Digital Health Webinar
- Details
- Category: Events
The digital healthcare ecosystem is evolving with rapid speed. Technologies such as AI, robotics, telemedicine, and precision medicine are a mix of challenges and opportunities. At the Digital Health Webinar, you will be introduced to digital medicine and DTx, novel wearables, data collection methods, regulatory issues, and other topics.
Bristol Myers Squibb Exercises Option to Develop Exscientia's AI-Designed, Immune-Modulating Drug Candidate
- Details
- Category: Industry
Exscientia, a clinical-stage, artificial intelligence (AI)-driven pharmatech company, today announced that Bristol Myers Squibb has elected to in-license an immune-modulating drug candidate created by Exscientia. Exscientia has two active collaborations with Bristol Myers Squibb, which together focus on multiple therapeutic areas, including oncology and immunology.
MEDICA is and Remains the International Platform for Start-Ups
- Details
- Category: Events
15 - 18 November 2021, Düsseldorf, Germany.The MEDICA start-up COMPETITION, the Healthcare Innovation World Cup, the MEDICA START-UP PARK and more than 100 start-ups with pitches in the MEDICA CONNECTED HEALTHCARE FORUM show that the world’s leading medical trade fair MEDICA in Düsseldorf has also established itself as the international platform for start-ups.
Abbott Receives FDA Clearance for its Imaging Technology Using AI
- Details
- Category: Industry
Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. This innovative imaging software combines OCT with artificial intelligence (AI) to provide physicians an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making and provide the best pathway for treatment.
Artificial Intelligence in Medicine Regulation
- Details
- Category: Development
The International Coalition of Medicines Regulatory Authorities (ICMRA) sets out recommendations to help regulators to address the challenges that the use of artificial intelligence (AI) poses for global medicines regulation, in a report published today.
AI includes various technologies (such as statistical models, diverse algorithms and self-modifying systems) that are increasingly being applied across all stages of a medicine's lifecycle: from preclinical development, to clinical trial data recording and analysis, to pharmacovigilance and clinical use optimisation.
Deep Learning Model Classifies Brain Tumors with Single MRI Scan
- Details
- Category: Research
Researchers Take Step Toward Next-Generation Brain-Computer Interface System
- Details
- Category: Research
Siemens Healthineers Adds Pathway for Lung Cancer to its AI-based Clinical Decision Support Software
- Details
- Category: Siemens Healthineers
Siemens Healthineers presents its second pathway for its AI-Pathway Companion(1) at the Healthcare Information and Management Systems Society Global Health Conference 2021 (HIMSS 21). This new pathway is focused on non-small cell lung cancer, supporting personalized and standardized decision-making along the whole treatment process(2).
Philips Introduces New HealthSuite Solutions to Drive Healthcare's Digital Transformation
- Details
- Category: Philips
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the introduction of two new Philips HealthSuite solutions that are secure, cloud-based and intended to break down barriers across patient care in a scalable, cost-effective model.
Brain Connectivity can Build Better AI
- Details
- Category: Research
By examining MRI data from a large Open Science repository, researchers reconstructed a brain connectivity pattern, and applied it to an artificial neural network (ANN). An ANN is a computing system consisting of multiple input and output units, much like the biological brain.